TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
|
| | | |
| | TRIAL 01-05-1 | |
| | Control material NO. | 01-05-1-1 | 01-05-1-2 | 01-05-1-3 | 01-05-1-4 | Non treponemal test | NS | NS | Non Reactive | Non Reactive | Treponemal test | Reactive | Reactive | Non Reactive | Non Reactive |
| |
| | | |
| | TRIAL 01-05-2 | |
| | Control material NO. | 01-05-2-1 | 01-05-2-2 | 01-05-2-3 | 01-05-2-4 | Non treponemal test | Non Reactive | NS | Non Reactive | Non Reactive | Treponemal test | Non Reactive | Reactive | Non Reactive | Non Reactive |
| |
| | | |
| | TRIAL 01-05-3 | |
| | Control material NO. | 01-05-3-1 | 01-05-3-2 | 01-05-3-3 | 01-05-3-4 | Non treponemal test | NS | NR | NS | NS | Treponemal test | R | R | R | R |
| |
| | | |
| | TRIAL 01-05-4 | |
| | Control material NO. | 01-05-4-1 | 01-05-4-2 | 01-05-4-3 | 01-05-4-4 | Non treponemal test | NON REACTIVE | REACTIVE
1:2 | NON REACTIVE | REACTIVE
1:2 | Treponemal test | NON REACTIVE | REACTIVE | NS | REACTIVE |
| |
| | | |
| | | |
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM |
| | | |
| | TRIAL 02-05-1 | |
| | Control material NO. | 02-05-1-1 | 02-05-1-2 | 02-05-1-3 | 02-05-1-4 | HBsAg | POSITIVE
311± 55 s/n | NEGATIVE
1.56 ± 0.84 s/n | POSITIVE
218 ± 31 s/n | POSITIVE
223 ± 32 s/n | antiHBs | NEGATIVE
0.12 ± 0.14 mIU/ml | NS | NEGATIVE
0.12 ± 0.14 mIU/ml | NEGATIVE
0.05±0.08 mIU/ml | antiHBc | POSITIVE | POSITIVE | POSITIVE | POSITIVE | HBeAg | POSITIVE | NEGATIVE | POSITIVE | POSITIVE | antiHBe | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE |
| |
| | | |
| | TRIAL 02-05-2 | |
| | Control material NO. | 02-05-2-1 | 02-05-2-2 | 02-05-2-3 | 02-05-2-4 | HBsAg | NEGATIVE
1.2 ± 1.1 s/n | NEGATIVE
1.3 ±1.4 s/n | POSITIVE
324 ±43 s/n | POSITIVE
327 ± 38 s/n | antiHBs | POSITIVE
664 ±155 mIU/ml | POSITIVE
660 ±156 mIU/ml | NEGATIVE
0.8 ±1.2 mIU/ml | NEGATIVE
1±1.2 mIU/ml | antiHBc | POSITIVE | POSITIVE | POSITIVE | POSITIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | POSITIVE | POSITIVE | POSITIVE | POSITIVE |
| |
| | | |
| | TRIAL 02-05-3 | |
| | Control material NO. | 02-05-3-1 | 02-05-3-2 | 02-05-3-3 | 02-05-3-4 | HBsAg | POSITIVE
248 ± 21 s/n | NEGATIVE
1.1 ± 0.1 s/n | NS | NEGATIVE
1.1 ± 0.1 s/n | antiHBs | NEGATIVE
0.1 mIU/ml | POSITIVE
230 ± 43 mIU/ml | NEGATIVE
0.1 mIU/ml | POSITIVE
224 ± 28 mIU/ml | antiHBc | POSITIVE | POSITIVE | POSITIVE | POSITIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | POSITIVE | NS | NS | NS |
| |
| | | |
| | TRIAL 02-05-4 | |
| | Control material NO. | 02-05-4-1 | 02-05-4-2 | 02-05-4-3 | 02-05-4-4 | HBsAg | NEGATIVE
1.38 ± 0.38 s/n | POSITIVE
362 ± 38 s/n | NEGATIVE
1.8 ± .2 s/n | POSITIVE
369 ± 35 s/n | antiHBs | POSITIVE
210 ± 69 mIU/ml | NEGATIVE
1 ± 2 mIU/ml | POSI TIVE
203 ± 72 mIU/ml | NEGATIVE
1 ± 2 mIU/ml | antiHBc | POSITIVE | POSITIVE | POSITIVE | POSITIVE | HBeAg | POSITIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | NEGATIVE | POSITIVE | POSITIVE | POSITIVE |
|
